Cannovum AG

  • WKN: A2LQU2
  • ISIN: DE000A2LQU21
  • Land: Deutschland

Nachricht vom 28.09.2021 | 09:00

Cannovum AG expands cannabis wholesale license and enters the active ingredient market

DGAP-News: Cannovum AG / Key word(s): Regulatory Approval
28.09.2021 / 09:00
The issuer is solely responsible for the content of this announcement.

Cannovum AG (Düsseldorf, Munich, Hamburg, Berlin stock exchanges, gettex: ISIN DE000A2LQU21) is expanding its wholesale license through its subsidiary, Cannovum Health eG. The expansion includes the active ingredient license, which enables the trading of active pharmaceutical ingredients. Cannovum is now authorized to distribute dronabinol, the first cannabis-based active ingredient, to pharmacies.

Active pharmaceutical ingredients are the components of a medication that are responsible for its efficacy. They trigger the essential biochemical process that ensures the medication acts in a specific way in the human body. One of the most important active ingredients of cannabis is THC, which is considered to have the greatest pharmaceutical potential and therapeutic efficacy.

Cannovum's scientific sales force has undergone intensive training with medical professionals, including for the new THC active ingredients, to assist physicians and pharmacists with individual cannabis-based therapies.

With the active ingredient license, Cannovum can now deal with active pharmaceutical ingredients in general and is not limited to dronabinol. In addition, Cannovum already holds the pharmaceutical wholesale licenses, including the GMP license required to map manufacturing steps in Germany.

"We want to improve patient care and that's why we decided to add active substances to our portfolio. Active ingredients are the core element of every medication and indispensable in the effective therapy of patients. We want to give physicians the opportunity to find an effective individual treatment for each of their patients, because every patient deserves the best therapy," says Pia Marten, CEO of Cannovum AG.



28.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

IPO im Fokus

MIT SICHERHEIT AUFS PARKETT. UNSER BÖRSENGANG ZUR WACHSTUMSBESCHLEUNIGUNG

ISIN: DE000A3CM708
Grundkapital (vor IPO): 3.120.000 EUR
Angebotene Aktien: bis zu 690.000 Aktien
Zeichnungsfrist: 11.10.2021 bis voraus. 25.10.2021
Bookbuildingspanne: 3,30 bis 3,60 Euro
Börse: Börse Düsseldorf

Rechtlich maßgeblicher Wertpapierprospekt auf sdm-se.de

Event im Fokus

Termine 2021

10. Juni 2021:Fachkonferenz Immobilien

14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure

13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie

10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix

„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“

GBC im Fokus

Börsengang sdm SE: Attraktives Investment

Der Sicherheitsdienstleister sdm SE führt derzeit einen Börsengang am Primärmarkt der Börse Düsseldorf durch. Die Mittel des Börsengangs sollen die Wachstumsstrategie finanzieren und die Ertragskraft deutlich steigern. Im Rahmen unseres DCF-Bewertungsmodells haben wir einen fairen Unternehmenswert (Post Money) zum Ende des Geschäftsjahres 2022 in Höhe von 15,23 Mio. € bzw. 4,09 € je sdm-Aktie ermittelt. Unter einem Preis von 3,50 € pro Aktie sehen wir sdm als ein attraktives Investment und stufen die Aktie mit dem Rating „Kaufen“ ein.

News im Fokus

Linde plc: Linde Reports Third-Quarter 2021 Results (Earnings Release Tables Attached) (news with additional features)

28. Oktober 2021, 11:59

Aktueller Webcast

TRATON SE

Pressekonferenz – Zwischenmitteilung 9M 2021 - Webcast

28. Oktober 2021

Aktuelle Research-Studie

Vectron Systems AG

Original-Research: Vectron Systems AG (von Sphene Capital GmbH): Sell

28. Oktober 2021